Discover the most comprehensive publication, so far, of inherited risk factors that confer risk of clonal haematopoiesis and the role COSMIC played in exploring upstream causes & downstream consequences of the disease.
With 1.24 million yearly occurrences, haematological cancers are the fifth most common type of cancer in the world. Here’s a sneak peak into three papers curated as part of our v97 update, each highlighting unique areas of research improving the outcomes for haematological cancer patients.
Copy Number Signatures are the latest addition to COSMIC Mutational Signatures, I caught up with one of the leads, Dr Ludmil Alexandrov, to discuss the key findings, utility of the data, and hopes for the future.
Read about the five emerging trends we took away from our time at AACR-2022
World Cancer Day is asking us to pull together to #ClosetheCareGap and remove barriers to treatment. So how is COSMIC playing a part? By tackling rare cancers head on.
COSMIC's Cancer Mutation Census (CMC) is a new tool that identifies and characterises the likely somatic mutations driving cancer. Read more about the development and data behind CMC with Senior Bioinformatician, Bhavana Harsha.
a focus on rare lung cancers and rare pancreatic cancers, and curation of somatic mutations in 12 hallmark apoptosis genes. Along with this, 9 cancer hallmark genes data are also updated. Find out more before exploring the v94 release.
After our very successful and exciting Actionability release v93, we are now gearing up for COSMIC v94 release in the coming weeks. This release is focused on our high quality manual curations including 2 new expertly curated genes, a focus on rare lung cancers and rare pancreatic cancers, and curation of somatic mutations in 12 hallmark apoptosis genes. Along with this, 9 cancer hallmark genes data are also updated.